Mechano-transcription of COX-2 is a common response to lumen dilation of the rat gastrointestinal tract

Neurogastroenterology and Motility

Volumn 24, Issue 7, 2012, Pages

  Lin, Y M ^a   Li, F ^a   Shi, X Z ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

COX 2; Lumen dilation; Mechanical stress; Motility; Obstruction

Indexed keywords

CYCLOOXYGENASE 2; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON DILATATION; CONTROLLED STUDY; ESOPHAGUS; ESOPHAGUS OBSTRUCTION; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL TRACT; GENE EXPRESSION; ILEUM; INTESTINE DISTENSION; LOWER ESOPHAGUS SPHINCTER; MALE; MECHANICAL STRESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYLORUS; RAT; SMALL INTESTINE OBSTRUCTION; SMOOTH MUSCLE; SMOOTH MUSCLE CONTRACTILITY; STOMACH EMPTYING; STOMACH FUNDUS; STOMACH OBSTRUCTION; TISSUE CULTURE;

ANIMALS; BLOTTING, WESTERN; CYCLOOXYGENASE 2; DILATATION; GASTRIC EMPTYING; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; MALE; MECHANOTRANSDUCTION, CELLULAR; MUSCLE CONTRACTION; MUSCLE, SMOOTH; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TRANSCRIPTOME;

EID: 84862684658     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2012.01918.x     Document Type: Article

References (51)

1. Beck WC, Sharp KW. Achalasia. Surg Clin North Am 2011; 91: 1031-7.
2. Kraichely RE, Farrugia G. Achalasia: physiology and etiopathogenesis. Dis Esophagus 2006; 19: 213-23.
3. Gonzalez M, Mearin F, Vasconez C, Armengol JR, Malagelada JR. Oesophageal tone in patients with achalasis. Gut 1997; 41: 291-6.
4. Russell JC, Welch JP. Pathophysiology of Bowel Obstruction. In: Welch JP, ed. Bowel Obstruction. Philadelphia, PA: W.B. Saunders, 1990: 28-58.
5. Summers RW. Chapter 39, Vol. 1, Approach to the patient with ileus and obstruction. In: Yamada T, Alpers DH, Laine L, Owyang C, Powell DW, eds. Textbook of Gastroenterology. Philadelphia, PA: Lippincott Williams & Wilkins, 1999: 842-58.
6. Summers RW, Anuras S, Green J. Jejunal manometry patterns in health, partial intestinal obstruction and pseudo-obstruction. Gastroenterology 1983; 85: 1290-300.
7. Bertoni S, Gabella G, Ghizzardi P et al. Motor response of rat hypertrophic intestine following chronic obstruction. Neurogastroenterol Motil 2004; 16: 365-74.
8. Won KJ, Suzuki T, Hori M, Ozaki H. Motility disorder in experimentally obstructed intestine: relationship between muscularis inflammation and disruption of the ICC network. Neurogastroenterol Motil 2006; 18: 53-61.
9. Shi XZ, Lin YM, Powell DW, Sarna SK. Pathophysiology of motility dysfunction in bowel obstruction: role of stretch-induced COX-2. Am J Physiol Gastrointest Liver Physiol 2011; 300: G99-108.
10. Ohshiro K, Puri P. Pathogenesis of infantile hypertrophic pyloric stenosis: recent progress. Pediatr Surg Int 1998; 13: 243-52.
11. Mohammed AA, Benmousa A, Almeghaiseeb I, Alkarawi M. Gastric outlet obstruction. Hepatogastroenterology 2007; 54: 2415-20.
12. Fisher RS. Gastroduodenal motility disturbances in man. Scan J Gastroenterol 1985; 109: 59-68.
13. Karamanolis G, Caenepeel P, Arts J, Tack J. Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction? Gut 2007; 56: 29-36.
14. Kumar A, Attaluri A, Hashmi S, Schulze KS, Rao SS. Visceral hypersensitivity and impaired accommodation in refractory diabetic gastroparesis. Neurogastroenterol Motil 2008; 20: 635-42.
15. Levin AA, Levine MS, Rubesin SE, Laufer I. An 8-year review of barium studies in the diagnosis of gastroparesis. Clin Radiol 2008; 63: 407-14.
16. Takahashi T, Kojima Y, Tsunoda Y et al. Impaired intracellular signal transduction in gastric smooth muscle of diabetic BB/W rats. Am J Physiol 1996; 270: G411-7.
17. James AN, Ryan JP, Crowell MD, Parkman HP. Regional gastric contractility alterations in a diabetic gastroparesis mouse model: effects of cholinergic and serotoninergic stimulation. Am J Physiol Gastrointest Liver Physiol 2004; 287: G612-9.
18. O'Brien PE. Bariatric surgery: mechanisms, indications and outcomes. J Gastroenterol Hepatol 2010; 25: 1358-65.
19. de Jong JR, Tiethof C, van Ramshorst B, Gooszen HG, Smout AJPM. Esophageal dilation after laparoscopic adjustable gastric banding: a more systematic approach is needed. Surg Endosc 2009; 23: 2802-8.
20. Naef M, Mouton WG, Naef U, van der Weg B, Maddern GJ, Wagner HE. Esophageal dysmotility disorders after laparoscopic gastric banding - an underestimated complication. Ann Surg 2011; 253: 285-90.
21. Suter M, Dorta G, Giusti V, Calmes JM. Gastric banding interferes with esophageal motility and gastroesophageal reflux. Arch Surg 2005; 140: 639-43.
22. Ferrario A, Fisher AM, Rucher N, Gomer CJ. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. Cancer Res 2005; 65: 2551-6.
23. Linden DR, Sharkey KA, Ho W, Mawe GM. Cyclooxygenase-2 contributes to dysmotility and enhanced excitability of myenteric AH neurones in the inflamed guinea pig distal colon. J Physiol 2004; 557(Pt 1): 191-205.
24. Gebhart GF. Visceral pain-peripheral sensitization. Gut 2000; 47(Suppl. 4): 54-5.
25. Zhang HQ, Al-Chaer ED, Willis WD. Effect of tactile inputs on thalamic responses to noxious colorectal distension in rats. J Neurophysiol 2002; 88: 1185-96.
26. Mönnikes H, Rüter J, König M et al. Differential induction of c-fos expression in brain nuclei by noxious and non-noxious colonic distension: role of afferent C-fibers and 5-HT3 receptors. Brain Res. 2003; 966: 253-64.
27. Shi XZ, Lindholm PF, Sarna SK. NF-kappa B activation by oxidative stress and inflammation suppresses contractility in colonic circular smooth muscle cells. Gastroenterology 2003; 124: 1369-80.
28. Shi XZ, Pazdrak K, Saada N, Dai B, Palade P, Sarna SK. Negative transcriptional regulation of human colonic smooth muscle Cav1.2 channels by p50 and p65 subunits of nuclear factor-kappaB. Gastroenterology 2005; 129: 1518-32.
29. Shi XZ, Sarna SK. Transcriptional regulation of inflammatory mediators secreted by human colonic circular smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 2005; 289: G274-84.
30. Shi XZ, Sarna SK. Gene therapy with VIP, VIP receptor agonists and VIP receptor antagonists: a novel approach to designing pro-motility and anti-motility agents. Am J Physiol Gastrointest Liver Physiol 2008; 295: G187-96.
31. Shi XZ, Winston JH, Sarna SK. Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 2011; 300: G41-51.
32. Lin YM, Sarna SK, Shi XZ. Prophylactic and therapeutic benefits of COX-2 inhibitor on motility dysfunction in bowel obstruction: roles of pGE2 and EP receptors. Am J Physiol Gastrointest Liver Physiol 2012; 302: G267-75.
33. Li F, Lin YM, Sarna SK, Shi XZ. Intracellular signaling mechanism of stretch-induced expression of COX-2 in colonic smooth muscle cells (Abstract). Gastroenterology 2011; 140: S120.
34. Sallam HS, Oliveira HM, Gan HT, Herndon DN, Chen JD. Ghrelin improves burn-induced delayed gastrointestinal transit in rats. Am J Physiol Regul Integr Comp Physiol 2007; 292: R253-7.
35. Prihoda M, Flatt A, Summers RW. Mechanisms of motility changes during acute intestinal obstruction in the dog. Am J Physiol 1984; 247: G37-42.
36. Karamanolis G, Tack J. Promotility medications - now and in the future. Dig Dis 2006; 24: 297-307.
37. Traut U, Brugger L, Kunz R et al. Systemic prokinetic pharmacologic treatment for postoperative adynamic ileus following abdominal surgery in adults (Review). Cochrane Database Syst Rev 2008; 1: CD004930.
38. Reddymasu SC, Soykan I, McCallum RW. Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol 2007; 102: 2036-45.
39. Manabe N, Wong BS, Camilleri M. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders. Expert Opin Investig Drugs 2010; 19: 765-75.
40. Sanger GJ. Translating 5-HT receptor pharmacology. Neurogastroenterol Motil 2009; 21: 1235-8.
41. Sarna SK, Gonzalez A, Ryan RP. Enteric locus of action of prokinetics: ABT-229, motilin, and erythromycin. Am J Physiol Gastrointest Liver Physiol 2000; 278: G744-52.
42. Meijssen MA, Tilanus HW, van Blankenstein M et al. Achalasia complicated by oesophageal squamous cell carcinoma: a prospective study in 195 patients. Gut 1992; 33: 155-8.
43. Sandler RS, Nyren O, Ekbom A et al. The risk of esophageal cancer in patients with achalasia: a population-based study. JAMA 1995; 274: 1359-62.
44. Zendehdel K, Nyrén O, Edberg A, Ye W. Risk of esophageal adenocarcinoma in achalasia patients, a retrospective cohort study in Sweden. Am J Gastroenterol 2011; 106: 57-61.
45. Buskens CJ, Ristimaki A, Offerhaus DJ, van Lanschot JJ. Role of cyclooxygenase-2 in the development and treatment of oesophageal adenocarcinoma. Scand J Gastroenterol Suppl 2003; 239: 87-93.
46. Wu WK, Sung JJ, Lee CW, Yu J, Cho CH. Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms. Cancer Lett 2010; 295: 7-16.
47. Gupta RA, Dubois RN. Cyclooxygenase-2 inhibitor therapy for the prevention of esophageal adenocarcinoma in Barrett's esophagus. J Natl Cancer Inst 2002; 94: 406-7.
48. Varela JE. Barrett's esophagus: a late complication of laparoscopic adjustable gastric banding. Obes Surg 2010; 20: 244-6.
49. Melstrom LG, Bentrem DJ, Salvino MJ, Blum MG, Talamonti MS, Printen KJ. Adenocarcinoma of the gastroesophageal junction after bariatric surgery. Am J Surg 2008; 196: 135-8.
50. Korswagen L A, Schrama J G, Bruins Slot W, Hunfeld M A. Adenocarcinoma of the lower esophagus after placement of a gastric band. Obes Surg 2009; 19: 389-92.
51. Stauffer JA, Mathew J, Odell JA. Esophageal adenocarcinoma after laparoscopic gastric band placement for obesity. Dis Esophagus 2011; 24: E8-10.